Mobile health intervention for type 2 diabetes management delivered by community health workers and clinical pharmacists: Intervention costs and healthcare resource utilization
The mDAS intervention incurred modest implementation costs. It did not result in significant differences in short-term HCRU and associated costs when compared to usual care. Future research should explore specific mechanisms impacting HCRU and the long-term cost-effectiveness of implementing such interventions more broadly in nonacademic clinical environments.
Authors
- Mrinmayee Joshi (ORCID: https://orcid.org/0000-0002-1900-4103)
- Daniel R. Touchette (ORCID: https://orcid.org/0000-0003-1972-8934)
- A. Simon Pickard (ORCID: https://orcid.org/0000-0001-5645-7091)
- Ben S. Gerber (ORCID: https://orcid.org/0000-0003-4367-6396)
- Lisa Kay Sharp (ORCID: https://orcid.org/0000-0002-7809-9042)
- Kibum Kim (ORCID: https://orcid.org/0000-0002-8676-7434)
Institutions
- University of Massachusetts Chan Medical School (US)
- University of Illinois Chicago (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1093/ajhp/zxaf153
- Citations
- 1
- Primary Topic
- Mobile Health and mHealth Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.82